2 offres de recrutement pour enGene Boston, MA :
enGene (NASDAQ: ENGN) is a late-stage biotechnology company mainstreaming genetic medicines through the delivery... are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX......
3 octobre 2025
Recrutement Director/ Senior Director, Regulatory Affairs Operations
enGene (NASDAQ: ENGN) is a late-stage biotechnology company mainstreaming genetic medicines through the delivery... are unresponsive to BCG. Detalimogene voraplasmid was developed using enGene's proprietary Dually Derivatized Oligochitosan (DDX......
11 septembre 2025